New Jersey Senate Passes Bill Requiring Pharmacists To Tell Consumers if Generic Drugs Can Replace Brand-Name Prescriptions
The New Jersey Senate on Thursday unanimously passed legislation (A 2030) that would require pharmacists to inform consumers when they have substituted generic drugs for brand-name prescriptions, the Newark Star-Ledger reports. The General Assembly approved the legislation in February and it now moves to Gov. Jon Corzine (D).
If Corzine signs the bill, the law would take effect within 180 days, making New Jersey the first state in the U.S. to have such a requirement. State Sen. Christopher Bateman (R) said, "We're hoping that other states will follow our lead" (Megerian, Newark Star-Ledger, 5/22).